NCT02998788Recruiting
Risk Evaluation and Management in Heart Failure
Source: ClinicalTrials.gov · Last updated 20 Dec 2016 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is an prospective study conducted in a Chinese heart failure population. The study investigates the effects of cardiovascular disease risk factors such as lifestyle behaviors,biomarkers and intermediate diseases on heart failure prognosis.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 10 Dec 2016
- Start date
- Jun 2016
- Primary completion date
- Dec 2026
- Lead sponsor
- Ruijin Hospital
- Diseases
- Heart failure
- NCT number
- NCT02998788
What you commit to
- Study type: Observational
- Planned participants: 1000
- From Jun 2016 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- expressed refusal to participate in the baseline investigation or follow-up visits Severe co-morbidity associated with a reduction in life expectancy of less than 12 months
Who the study is looking for
- aged 18 and above
- inpatient with one of the following clinical situations:
- congestive heart failure (pulmonary edema,pulmonary congestion or peripheral edema)
- cardiogenic shock
- Insufficient high output cardiac
- with impaired cardiac function diagnosed by echocardiography
- able to provide informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ruijin Hospital Shanghai Jiaotong University School of Medicine Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.